WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced the pricing of an underwritten public offering of 4.5 million shares of its common stock at a price of $10.00 per share, less underwriting discounts and commissions. The size of the offering was upsized from 3.3 million shares to 4.5 million shares, raising aggregate gross proceeds of $45 million. Tetraphase has granted the underwriters a 30-day option to purchase 675,000 additional shares of common stock on the same terms and conditions. The offering is expected to close on or about November 13, 2013, subject to customary closing conditions.
Don’t forget, hundreds of biopharma companies are hiring! (We know you can’t resist.)
